UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

212th ENMC international workshop: animal models of congenital muscular dystrophies may 29th-31st, 2015 in naarden, the netherlands

Neuromuscular disorders : NMD, 2016-03, Vol.26 (3)

2016

Volltextzugriff (PDF)

212th ENMC International Workshop:: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29–31 May 2015

Neuromuscular disorders : NMD, 2016-03, Vol.26 (3), p.252-259

2016

Volltextzugriff (PDF)

Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis

The Journal of experimental medicine, 2006-04, Vol.203 (4), p.1007-1019

2006

Volltextzugriff (PDF)

T.P.5.07 Substantial improvement of laminin α2 chain deficiency by laminin α1 chain overexpression persists throughout life

Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.618-618

2009

Volltextzugriff (PDF)

Muscular dystrophies involving the dystrophin–glycoprotein complex: an overview of current mouse models

Current Opinion in Genetics & Development, 2002-06, Vol.12 (3), p.349-361

2002

Volltextzugriff (PDF)

EM.O.1 E3 domain of laminin α1 chain that binds to dystroglycan is not essential for survival and muscle regeneration in laminin α1 chain mediated correction of laminin α2 chain deficiency

Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.598-599

2009

Volltextzugriff (PDF)

CONGENITAL MUSCULAR DYSTROPHIES

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S131

2018

Volltextzugriff (PDF)

CONGENITAL MUSCULAR DYSTROPHIES: P.333Laminin α1 chain overexpression has potentially broad therapeutic spectrum for LAMA2-CMD

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S131-S131

2018

Volltextzugriff (PDF)

Non-Muscle α-Dystroglycan Is Involved in Epithelial Development

The Journal of cell biology, 1995-07, Vol.130 (1), p.79-91

1995

Volltextzugriff (PDF)

Antibodies against domain E3 of laminin-1 and integrin alpha 6 subunit perturb branching epithelial morphogenesis of submandibular gland, but by different modes

The Journal of cell biology, 1995-04, Vol.129 (2), p.521-534

1995

Volltextzugriff (PDF)

P.331Effects of N-acetyl-L-cysteine and vitamin E on congenital muscular dystrophy type 1A disease progression in mice

Neuromuscular disorders : NMD, 2019-10, Vol.29, p.S163-S164

2019

Volltextzugriff (PDF)

Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation

Developmental biology, 2005, Vol.277 (1), p.255-269

2005

Volltextzugriff (PDF)

EM.P.3.02 Intracellular signaling pathway alterations in laminin α2 chain deficient skeletal muscle and brain

Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.574-574

2009

Volltextzugriff (PDF)

C.P.3.10 Analysing the role of the α/β-dystroglycan interface for skeletal muscle stability

Neuromuscular disorders : NMD, 2007, Vol.17 (9), p.872-872

2007

Volltextzugriff (PDF)

NEW THERAPEUTIC APPROACHES AND THEIR READOUT

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S90

2018

Volltextzugriff (PDF)

NEW THERAPEUTIC APPROACHES AND THEIR READOUT: O.14A mutation-independent approach via transcriptional upregulation of a disease modifier gene rescues muscular dystrophy in vivo

Neuromuscular disorders : NMD, 2018-10, Vol.28, p.S90-S90

2018

Volltextzugriff (PDF)

212th ENMC International Workshop

Neuromuscular disorders : NMD, 2016-03, Vol.26 (3), p.252-259

2016

Volltextzugriff (PDF)

Differential expression of neurotrophin receptors during renal development

Development (Cambridge), 1993-12, Vol.119 (4), p.977-989

1993

Volltextzugriff (PDF)

Biochemical Characterization of the Epithelial Dystroglycan Complex

The Journal of biological chemistry, 1999-09, Vol.274 (37), p.26609-26616

1999

Volltextzugriff (PDF)

Dystroglycan: a possible mediator for reducing congenital muscular dystrophy?

Trends in biotechnology (Regular ed.), 2007-06, Vol.25 (6), p.262-268

2007

Volltextzugriff (PDF)

Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex

The Journal of clinical investigation, 2001-01, Vol.107 (2), p.R1-R7

2001

Volltextzugriff (PDF)

Laminin Isoforms and Epithelial Development

Annals of the New York Academy of Sciences, 1998-10, Vol.857 (1), p.194-211

1998

Volltextzugriff (PDF)

Disruption of the β-Sarcoglycan Gene Reveals Pathogenetic Complexity of Limb-Girdle Muscular Dystrophy Type 2E

Molecular cell, 2000, Vol.5 (1), p.141-151

2000

Volltextzugriff (PDF)

Progressive Muscular Dystrophy in α-Sarcoglycan-Deficient Mice

The Journal of cell biology, 1998-09, Vol.142 (6), p.1461-1471

1998

Volltextzugriff (PDF)

Dystroglycan in development and disease

Current opinion in cell biology, 1998-10, Vol.10 (5), p.594-601

1998

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(90)
Tagungsberichte
(1)

Sprache

Englisch
(91)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Animals
(33)
Life Sciences & Biomedicine
(33)
Mice
(29)
Medicin Och Hälsovetenskap
(24)
Humans
(16)
Muscular Dystrophy
(14)
Female
(13)
Medical And Health Sciences
(13)
Laminin
(12)
Male
(12)
Cell Biology
(11)
Chemistry
(11)
Dystroglycans
(11)
Laminin - Genetics
(11)
Basic Medicine
(10)
In Situ Hybridization
(10)
Medicinska Och Farmaceutiska Grundvetenskaper
(10)
Physical Sciences
(10)
Biological And Medical Sciences
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

212th ENMC international workshop: animal models of congenital muscular dystrophies may 29th-31st, 2015 in naarden, the netherlands

212th ENMC International Workshop:: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29–31 May 2015

Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis

T.P.5.07 Substantial improvement of laminin α2 chain deficiency by laminin α1 chain overexpression persists throughout life

Muscular dystrophies involving the dystrophin–glycoprotein complex: an overview of current mouse models

EM.O.1 E3 domain of laminin α1 chain that binds to dystroglycan is not essential for survival and muscle regeneration in laminin α1 chain mediated correction of laminin α2 chain deficiency

CONGENITAL MUSCULAR DYSTROPHIES

CONGENITAL MUSCULAR DYSTROPHIES: P.333Laminin α1 chain overexpression has potentially broad therapeutic spectrum for LAMA2-CMD

Non-Muscle α-Dystroglycan Is Involved in Epithelial Development

Antibodies against domain E3 of laminin-1 and integrin alpha 6 subunit perturb branching epithelial morphogenesis of submandibular gland, but by different modes

P.331Effects of N-acetyl-L-cysteine and vitamin E on congenital muscular dystrophy type 1A disease progression in mice

Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation

EM.P.3.02 Intracellular signaling pathway alterations in laminin α2 chain deficient skeletal muscle and brain

C.P.3.10 Analysing the role of the α/β-dystroglycan interface for skeletal muscle stability

NEW THERAPEUTIC APPROACHES AND THEIR READOUT

NEW THERAPEUTIC APPROACHES AND THEIR READOUT: O.14A mutation-independent approach via transcriptional upregulation of a disease modifier gene rescues muscular dystrophy in vivo

212th ENMC International Workshop

Differential expression of neurotrophin receptors during renal development

Biochemical Characterization of the Epithelial Dystroglycan Complex

Dystroglycan: a possible mediator for reducing congenital muscular dystrophy?

Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex

Laminin Isoforms and Epithelial Development

Disruption of the β-Sarcoglycan Gene Reveals Pathogenetic Complexity of Limb-Girdle Muscular Dystrophy Type 2E

Progressive Muscular Dystrophy in α-Sarcoglycan-Deficient Mice

Dystroglycan in development and disease

Suchergebnisse filtern